You are here: Home

 Welcome to Elite Pharmaceuticals

 
 

Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tablets, pellets, capsules, granules and powders.  The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.

 
       Click here to be directed to Elite's 2014 Annual Meeting Information

 


Recent Press Releases:
4/14/2014 Elite Pharmaceuticals Secures Funding Commitment Of Up To $40 Million From Lincoln Park Capital, LLC

3/27/2014 Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs
- New Hire Brings Track Record of Success -


3/24/2014 Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine

3/10/2014 Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally

3/5/2014 Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200

 

Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com